Credit rating agency Moody's slashed its global economic and oil forecasts again on Tuesday, predicting ongoing coronavirus lockdowns would now see the G20 group of major economies contract 4 percent this year before bouncing back 4.8 percent in 2021.
The cuts by Moody's, though more narrowly-focused, look even more pessimistic than the -3 percent worldwide drop forecast by the International Monetary Fund this month, and the 2.4 percent contraction estimated by rival rating firm S&P Global.
Moody's individual country forecasts included a -5.7 percent slump in the United States, -6.5 percent plunges in both Japan and the euro zone and -7 percent and -8.2 percent ones in Britain and Italy. China is expected to manage just 1 percent growth though next year could see a strong 7.1 percent rebound.
"There are significant downside risks to our forecasts in the event that the pandemic is not contained and lockdowns have to be reinstated," Moody's said in a report.
Even without longer-duration lockdowns, a self-perpetuating dynamic could take hold "resulting in large-scale destruction of businesses and entire sectors, as well as a structurally high unemployment rate," it warned "and persistent malaise in consumption and investment."
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
Moody's forecasts feed into its closely-followed credit ratings of companies and countries. There has already been a blizzard of rating cuts since the crisis took hold, but the more dire projections will fuel worries of more to come.
Without a coordinated global effort to bring and keep the rate of COVID-19 infections down in all countries, Moody's said the risk of a resurgence in the virus and more severe economic outcomes was "high".
The rapid spread globally in only a few weeks indicated that even if a country can curb its infection rate enough to relax social distancing measures, as Korea has, a resurgence could easily occur.
Other risks stem from the potential for deep structural economic damage which could leave permanent scars on the hardest-hit sectors, as well as on employment and household wealth.
The shock is also transmitting unequally Moody's warned. With the poorest segments of society disproportionately affected, "the resulting increase in inequality could fuel social discontent and political unrest."
The agency also followed S&P in slashing its oil forecasts. It now expects benchmark Brent prices to average $35 per barrel and U.S. WTI crude to average $30 per barrel this year before ticking up to $45 and $40 respectively next year as economies perk up.
"The crisis has long-term implications for the structure of the global economy," Moody's said. "These changes will inevitably have costs in terms of efficiency and international trade. They could also have profound geopolitical implications".
Follow our full coverage of the coronavirus pandemic here.